cancer_study_identifier: brca_dldccc_2022
type_of_cancer: brca
name: Triple Negative Breast Cancer (DLDCCC, Cancer Discov 2022)
description: Whole exome sequencing of 59 pre-treatment and 16 post-treatment triple-negative breast cancer samples and their matched normals as part of microscaled poteogenomic analysis to identify markers of chemotherapy resistance and response.  
pmid: 36001024
citation: Anurag, Meenakshi et al. Cancer discovery 2022

